tiprankstipranks
Eloxx Pharmaceuticals (ELOX)
:ELOX
US Market

Eloxx Pharmaceuticals (ELOX) Income Statement

Compare
285 Followers

Eloxx Pharmaceuticals Income Statement

Last quarter (Q3 2023), Eloxx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Eloxx Pharmaceuticals's net income was $-3.59M. See Eloxx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 34.42M$ 66.02M$ 29.44M$ 50.55M$ 46.97M
Depreciation and Amortization
$ 695.00K$ 960.00K$ 571.00K$ 559.00K$ 216.00K
EBITDA
$ -33.37M$ -66.02M$ -33.45M$ -50.55M$ -46.15M
Operating Income
$ -34.42M$ -66.02M$ -33.45M$ -50.55M$ -47.56M
Other Income/Expenses
$ -1.65M$ -709.00K$ -1.12M$ -319.00K$ 502.00K
Pretax Income
$ -36.06M$ -66.73M$ -34.58M$ -50.87M$ -47.06M
Net Income
$ -36.06M$ -66.73M$ -34.58M$ -50.87M$ -47.19M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -16.65$ -38.15$ -34.47$ -53.46$ -58.19
Diluted EPS
$ -16.65$ -38.15$ -34.47$ -53.46$ -58.19
Weighted Average Shares Outstanding
2.17M 1.75M 1.00M 951.58K 810.91K
Weighted Average Shares Outstanding (Diluted)
2.17M 1.75M 1.00M 951.58K 810.91K
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis